SEC Form 4 insider trading filings tracked in real time from EDGAR

Tenjarla Srini — SVP, CMC & Formulation

Insider trading activity for Tenjarla Srini sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: SVP, CMC & Formulation
  • Company: Serina Therapeutics, Inc.
  • Total insider trades: 1
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 26, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 21, 2026 Tenjarla Srini SER Serina Therapeutics, Inc. BUY 85,558 N/A

← All executives · Full trades feed